Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Nature Communications|January 30, 2020
HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumorsKwon-Ho Song, Se Jin Oh, Suyeon Kim, et al.
Advanced Healthcare Materials|September 3, 2013
Immunologic and tissue biocompatibility of flexible/stretchable electronics and optoelectronicsGayoung Park, Hyun-Joong Chung, Kwanghee Kim, et al.
Frontiers in Immunology|September 6, 2021
IL-6 and IL-10 Levels, Rather Than Viral Load and Neutralizing Antibody Titers, Determine the Fate of Patients With Severe Fever With Thrombocytopenia Syndrome Virus Infection in South KoreaJeong Rae Yoo, Tae-Jin Kim, Sang Taek Heo, et al.
Cancer Research|February 14, 2018
Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG AxisSe Jin Oh, Hanbyoul Cho, Suhyun Kim, et al.
Frontiers in Immunology|July 10, 2026
Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF-β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infectionSu Yeon Kang, Jeong Rae Yoo, EunJin Bae, et al.
Cancer Immunology Research|June 21, 2017
SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune ToxicityJungsun Park, Amjad H Talukder, Seon A Lim, et al.
ACS Nano|April 2, 2014
Dissolution chemistry and biocompatibility of single-crystalline silicon nanomembranes and associated materials for transient electronicsSuk-Won Hwang, Gayoung Park, Chris Edwards, et al.
Autophagy|August 9, 2020
LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cellsSuyeon Kim, Hanbyoul Cho, Soon-Oh Hong, et al.
Cancer Research|July 19, 2017
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor CellsKwon-Ho Song, Chel Hun Choi, Hyo-Jung Lee, et al.
Molecular Cancer|February 29, 2024
Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanomaJeongsoo Kim, Tae-Jin Kim, Sehyun Chae, et al.
Pageof 25